Cytosorbents Corporation
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. The company's flagship product is CytoSorb, an extracorporeal blood purification cartridge for the treatment of massive inflamm… Read more
Market Cap & Net Worth: Cytosorbents Corporation (HQE1)
Cytosorbents Corporation (F:HQE1) has a market capitalization of $17.38 Million (€16.93 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #26054 globally and #2852 in its home market, demonstrating a -17.57% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cytosorbents Corporation's stock price €0.54 by its total outstanding shares 31651800 (31.65 Million).
Cytosorbents Corporation Market Cap History: 2015 to 2026
Cytosorbents Corporation's market capitalization history from 2015 to 2026. Data shows change from $179.57 Million to $17.38 Million (-19.97% CAGR).
Cytosorbents Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cytosorbents Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of HQE1 by Market Capitalization
Companies near Cytosorbents Corporation in the global market cap rankings as of March 19, 2026.
Key companies related to Cytosorbents Corporation by market ranking:
- MODULIGHT OY EO 1 (F:78W): Ranked #26045 globally with a market cap of $17.68 Million USD ( €17.23 Million EUR).
- PT Energi Mega Persada Tbk (F:HFK): Ranked #26046 globally with a market cap of $17.68 Million USD ( €17.23 Million EUR).
- Jeil Technos Co.Ltd (KQ:038010): Ranked #26055 globally with a market cap of $17.64 Million USD ( ₩25.83 Billion KRW).
- Glidelogic Corp. (PINK:GDLG): Ranked #26056 globally with a market cap of $17.64 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #26045 | MODULIGHT OY EO 1 | F:78W | $17.68 Million | €1.09 |
| #26046 | PT Energi Mega Persada Tbk | F:HFK | $17.68 Million | €0.07 |
| #26055 | Jeil Technos Co.Ltd | KQ:038010 | $17.64 Million | ₩6020.00 |
| #26056 | Glidelogic Corp. | PINK:GDLG | $17.64 Million | $1.06 |
Cytosorbents Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, Cytosorbents Corporation's market cap moved from $179.57 Million to $ 17.38 Million, with a yearly change of -19.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €17.38 Million | +0.94% |
| 2025 | €17.22 Million | -39.08% |
| 2024 | €28.27 Million | -5.84% |
| 2023 | €30.02 Million | -28.21% |
| 2022 | €41.81 Million | -64.21% |
| 2021 | €116.83 Million | -43.81% |
| 2020 | €207.93 Million | +83.70% |
| 2019 | €113.19 Million | -47.61% |
| 2018 | €216.06 Million | +21.79% |
| 2017 | €177.39 Million | +7.06% |
| 2016 | €165.70 Million | -7.73% |
| 2015 | €179.57 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Cytosorbents Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.38 Million USD |
| MoneyControl | $17.38 Million USD |
| MarketWatch | $17.38 Million USD |
| marketcap.company | $17.38 Million USD |
| Reuters | $17.38 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.